Please use this identifier to cite or link to this item:
Erbsland, Manfred
Wille, Eberhard
Year of Publication: 
Series/Report no.: 
ZEW Discussion Papers No. 94-11
From the viewpoint of regulation, this paper investigates the effects of both the Health Care Refonn Act (Gesundheitsreformgesetz, GRG) and the Structural Health Care Act (Gesundheitsstrukturgesetz, GSG) on phannaceutical markets. Apart from the change in the intensity of regulation, the main focus is on the relative significance of self-regulation (or corporatism) on the one hand, and govemment regulation on the other. As our analysis demonstrates, in contrast to GRG, the impact of GSG has been - at least temporarily - to shift emphasis away from corporatism towards regulation directly imposed by govemment.
Document Type: 
Working Paper
Document Version: 
Digitized Version

Files in This Item:

Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.